Astemizole
Catalog No. A13899
Astemizole是一种有效的抗组胺药物（H1-受体拮抗剂，IC50 = 4 nM），对多巴胺，5-HT和毒蕈碱乙酰胆碱受体具有选择性。该化合物显示出有效的hERG K+通道阻断活性（IC50 = 0.9 nM），在体外多药耐药菌株中具有抗疟疾活性（IC50 = 227-734 nM），并已被用作分子伴侣来纠正折叠缺陷并恢复蛋白质功能 hERG通道的某些突变形式。
- Reiko Watanabe, .et al. Development of an In Silico Prediction Model for P-glycoprotein Efflux Potential in Brain Capillary Endothelial Cells toward the Prediction of Brain Penetration, J Med Chem, 2021, Mar 11;64(5):2725-2738 PMID: 33619967
| Catalog Num | A13899 |
|---|---|
| M. Wt | 458.57 |
| Formula | C28H31FN4O |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 68844-77-9 |
| Synonyms | Astemisan, Hismanal, Histamen, Paralergim |
| SMILES | COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F |
Astemizole是一种有效的抗组胺药物（H1-受体拮抗剂，IC50 = 4 nM），对多巴胺，5-HT和毒蕈碱乙酰胆碱受体具有选择性。该化合物显示出有效的hERG K+通道阻断活性（IC50 = 0.9 nM），在体外多药耐药菌株中具有抗疟疾活性（IC50 = 227-734 nM），并已被用作分子伴侣来纠正折叠缺陷并恢复蛋白质功能 hERG通道的某些突变形式。
| In vitro | DMSO | 91 mg/mL (198.44 mM) | |
| Water | Insoluble | ||
| Ethanol | 9 mg/mL | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 21.81 mL | 109.03 mL | 218.07 mL |
| 0.5 mM | 4.36 mL | 21.81 mL | 43.61 mL |
| 1 mM | 2.18 mL | 10.9 mL | 21.81 mL |
| 5 mM | 0.44 mL | 2.18 mL | 4.36 mL |
*The above data is based on the productmolecular weight 458.57. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.